echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > JAMA Oncology: Start using aspirin at a young age and the risk of colorectal cancer is significantly reduced!

    JAMA Oncology: Start using aspirin at a young age and the risk of colorectal cancer is significantly reduced!

    • Last Update: 2021-01-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Aspirin, as one of the three classic drugs in the history of medicine, has been in clinical application for hundreds of years, and is still a good medicine for heat relief, analgesics and anti-inflammatory drugs.
    With the development of medicine, numerous studies have found a link between aspirin heart disease, stroke, cancer (especially gastrointestinal cancer) and reduced all-cause mortality, and guidelines have been used as a level 1 prevention of cardiovascular disease in high-risk groups aged 50-59.
    , however, studies have shown that regular use of aspirin reduces the incidence of colorectal cancer in middle-age people, but at the same time increases side effects such as gastrointestinal bleeding.
    , when is it most effective for colorectal cancer patients to start taking aspirin?On January 21st, a study published in the journal JAMA Oncology showed that using aspirin before the age of 70 reduced the risk of colorectal cancer.
    , starting use after the age of 70 was not associated with reducing the risk of colorectal cancer.
    In this study, the researchers conducted a summary analysis of two large-scale U.S. queue studies, the Nurse Health Study (June 1, 1980-June 30, 2014) and the Health Professional Follow-up Study (January 1, 1986-January 31, 1986), which included a total of 94,540 participants over the age of 70.
    women to June 30, 2014 and men to January 31, 2014.
    unless melanoma skin cancer or inflammatory bowel disease, participants diagnosed with any cancer are excluded.
    70 or 70... MedSci Original Source: MedSci Original Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Mets Medicine and are not authorized to be reproduced by any media, website or individual, and are authorized to be reproduced with the words "Source: Mets Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.